Drug Profile
Interleukin-6 mutein
Alternative Names: FCE 27809; IL-6mLatest Information Update: 08 Jan 2001
Price :
$50
*
At a glance
- Originator ImClone Systems
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombocytopenia
Most Recent Events
- 08 Jan 2001 No-Development-Reported for Thrombocytopenia in Israel (Unknown route)
- 08 Jan 2001 No-Development-Reported for Thrombocytopenia in USA (Unknown route)
- 05 Nov 1997 Phase-II clinical trials for Thrombocytopenia in Israel (Unknown route)